Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dexmedetomidine/Lidocaine, Ketamine/Lidocaine and Lidocaine Alone on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries: Randomised Prospective Study

NCT06631625 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT06631625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06631625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dexmedetomidine/Lidocaine, Ketamine/Lidocaine and Lidocaine Alone on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries: Randomised Prospective Study
Lead sponsor
Alexandria University
Phase
Phase 1
Overall status
Completed
Start date
September 24, 2023
Completion date
September 24, 2024
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal cancer, pelvic cancer, proinflammatory cytokines, surgery